The State-of-art-in
Oncology Injectable

Cytopharma is the first pharmaceutical company in Africa & Middle East region entirely specialized in the manufacturing and marketing of generic cytotoxic drugs.

Established in Tunisia since 2011, Cytopharma’s purpose is to provide high quality and affordable oncology medicine for cancer patients all over the world, helping them successfully fighting the disease.

cyto 03
cytopharma oncology 01
A technician inspects anti-cancer drugs in vials at a lab of a pharmaceutical company in Lianyungang, Jiangsu province, China March 13, 2019. REUTERS/Stringer ATTENTION EDITORS - THIS IMAGE WAS PROVIDED BY A THIRD PARTY. CHINA OUT.


As a socially responsible company, we ensure that our decisions and actions respect the environment, human rights and have a positive social impact.


Medicines are more than just molecules. As a growing player in the pharmaceutical industry field, we are conscious of our responsibility and essential role to provide good health to our patients.

We put our know-how and commitment at the service of health and we are engaged to provide high quality and affordable oncological generic product.


The handling of cytotoxic, the mastery of injectable and the development of products in compliance with the strictest international and EU-GMP quality standards are our most precious know-how.


As a partner for oncology solutions we are open to: contract manufacturing, co-promotion, co-marketing and distribution.
Unit capacity per year
Marketed drugs
Country of marketing 
Average new MA per year